Status:
COMPLETED
Efficacy and Safety of the Alena App as a Treatment for Social Anxiety Disorder
Lead Sponsor:
Aya Technologies Limited
Conditions:
Social Anxiety Disorder (Social Phobia)
Social Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The present study is a randomised controlled trial that seeks to investigate the efficacy and safety of the Alena app as a treatment for social anxiety disorder.
Detailed Description
This will be a 10-week web-based parallel-group unblinded randomised controlled trial with an 8-week intervention period and a 2-week follow-up post-intervention. Participants will be randomly allocat...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Scored over 30 on the SPIN (indicating at least moderate social anxiety)
- Aged 18 or over
- Fluent in English
- Has access to a smartphone (iOS or Android) and the internet
- UK resident
- Exclusion criteria:
- Currently receiving therapy for their mental health
- Mental health medication has changed (dosage or presence) in the last 8 weeks
- Scores over 7 on the AUDIT-C and/or yes on either drug dependence question taken from the DUDIT (indicating drug or alcohol abuse)
- Previous experience with the Alena app through prior studies or user testing
Exclusion
Key Trial Info
Start Date :
March 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 7 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05987969
Start Date
March 20 2023
End Date
June 7 2023
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aya Technologies Limited
London, United Kingdom